These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 9062075)
21. A novel immunosuppressory peptide originating from the ubiquitin sequence. Pasikowski P; Goździewicz T; Stefanowicz P; Artym J; Zimecki M; Szewczuk Z Peptides; 2011 Dec; 32(12):2418-27. PubMed ID: 22008734 [TBL] [Abstract][Full Text] [Related]
22. Novel structural features of the human histocompatibility molecules HLA-DQ as revealed by modeling based on the published structure of the related molecule HLA-DR. Paliakasis K; Routsias J; Petratos K; Ouzounis C; Kokkinidis M; Papadopoulos GK J Struct Biol; 1996; 117(2):145-63. PubMed ID: 8931340 [TBL] [Abstract][Full Text] [Related]
23. Immunosuppressive activity of tyrosine analogues of cyclolinopeptide A. Wieczorek Z; Pedyczak A; Bodalski T; Lisowski M; Trojnar J; Zimecki M; Siemion IZ Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):213-6. PubMed ID: 1300986 [TBL] [Abstract][Full Text] [Related]
25. Bone sialoprotein peptides are potent inhibitors of breast cancer cell adhesion to bone. van der Pluijm G; Vloedgraven HJ; Ivanov B; Robey FA; Grzesik WJ; Robey PG; Papapoulos SE; Lowik CW Cancer Res; 1996 Apr; 56(8):1948-55. PubMed ID: 8620518 [TBL] [Abstract][Full Text] [Related]
26. Cyclodimerization of immunosuppressive fragment of HLA-DR molecule. Design, synthesis and ESI-MS/MS analysis. Biernat M; Cydzik M; Stefanowicz P; Kluczyk A; Artym J; Zimecki M; Szewczuk Z J Pept Sci; 2016 Aug; 22(8):525-32. PubMed ID: 27443978 [TBL] [Abstract][Full Text] [Related]
27. Immunomodulatory activity of conformationally restricted peptides related to TGF-beta-2 90-99 sequence. Wieczorek Z; Słoń JJ; Siemion IZ Arch Immunol Ther Exp (Warsz); 1996; 44(4):209-14. PubMed ID: 9017160 [TBL] [Abstract][Full Text] [Related]
28. Immunosuppressive activity of cyclolinopeptide A. Wieczorek Z; Bengtsson B; Trojnar J; Siemion IZ Pept Res; 1991; 4(5):275-83. PubMed ID: 1802239 [TBL] [Abstract][Full Text] [Related]
29. Immunomodulatory activity of disulphide bridged peptides related to lactoferrin immunosuppressive mini-domain. Wieczorek Z; Słoń J; Siemion IZ Pol J Pharmacol; 1995; 47(5):451-5. PubMed ID: 8868139 [TBL] [Abstract][Full Text] [Related]
30. Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptide. Dutta AS; Crowther M; Gormley JJ; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Jamieson A; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D J Pept Sci; 2000 Jul; 6(7):321-41. PubMed ID: 10946997 [TBL] [Abstract][Full Text] [Related]
31. Delineation of an active fragment and poly(L-proline) II conformation for candidacidal activity of bactenecin 5. Raj PA; Marcus E; Edgerton M Biochemistry; 1996 Apr; 35(14):4314-25. PubMed ID: 8605180 [TBL] [Abstract][Full Text] [Related]
33. Synthetic peptide mimics of the active domain of fibronectin. Davies JS; Orchison JJ; Jones GE Biochem Soc Trans; 1990 Dec; 18(6):1326-8. PubMed ID: 2088934 [No Abstract] [Full Text] [Related]
34. A cyclic pentapeptide derived from the second EGF-like domain of Factor VII is an inhibitor of tissue factor dependent coagulation and thrombus formation. Orning L; Fischer PM; Hu CK; Agner E; Engebretsen M; Husbyn M; Petersen LB; Orvim U; Llinas M; Sakariassen KS Thromb Haemost; 2002 Jan; 87(1):13-21. PubMed ID: 11848442 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and immunosuppressive activity of new cyclolinopeptide A analogs modified with beta-prolines. Katarzyńska J; Mazur A; Bilska M; Adamek E; Zimecki M; Jankowski S; Zabrocki J J Pept Sci; 2008 Dec; 14(12):1283-94. PubMed ID: 18821729 [TBL] [Abstract][Full Text] [Related]
36. Side chain cyclization based on serine residues: synthesis, structure, and activity of a novel cyclic analogue of the parathyroid hormone fragment 1-11. Caporale A; Sturlese M; Gesiot L; Zanta F; Wittelsberger A; Cabrele C J Med Chem; 2010 Nov; 53(22):8072-9. PubMed ID: 21028829 [TBL] [Abstract][Full Text] [Related]